• Videos
  • February 2022
  • 16 minutes

Mortality and Morbidity of COVID-19 Survivors

  • Dr. John J. Lefebre
Skip to Authors and Experts
In Brief

Curious about RGA's medical insights?  Contact us to learn more. 

This video was developed in conjunction with actuview, the first permanent international media platform for actuaries ( actuview content reflects contributions from actuarial institutions, corporate partners and industry professionals. RGA is actuview’s sponsoring partner.

RGA's Dr. John Lefebre reviews recent research, exploring factors that may influence the relative mortality risk of hospitalized patients versus matched control groups, including older age, preexisting comorbidities, and socioeconomic status.

Dr. Lefebre also investigates factors that may contribute to long COVID or post-COVID syndrome among survivors, including the role of undiagnosed medical conditions and preexisting comorbidities in increasing the risk of both long COVID and related symptoms among hospitalized survivors. He explores differences between the general and insured populations in incidence and prevalence, and also explores the potential benefits of vaccination in reducing risk in morbidity among survivors.

See also:  Coverage over the Long-Haul: Managing Disability Claims for long COVID

At RGA, we are eager to engage with clients to better understand and tackle the industry’s most pressing challenges together. Contact us to discuss and learn more about the RGA capabilities, resources, and solutions.  

More Like This...

Meet the Authors & Experts

Dr. John J. Lefebre
Vice President and Senior Global Medical Director, Global Medical